Delivery Order SPE2DB20D1109-SPE2DB25FP69V
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,855.22 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price, non-set-aside contract is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,204.35 and is scheduled for completion by December 9, 2025. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $7,810.81 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. The contract, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 15, 2026, by the Defense Logistics Agency for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat inflammatory conditions. The contract is valued at $2,387.94 with a firm fixed-price structure and an ultimate completion date of January 16, 2026. This delivery order was competitively awarded with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 18, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other inflammatory conditions. The order, valued at $2,387.94 with a firm fixed price structure, will be fulfilled from the contractor's Conshohocken, Pennsylvania facility and is scheduled for completion by November 19, 2025. This is a non-set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic medication used to treat autoimmune conditions. The contract is valued at $6,817.16 and is classified as a firm fixed-price delivery order with an ultimate completion date of October 23, 2025. The award uses no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a specialty pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, valued at $11,500.66, is scheduled for completion by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used in the treatment of inflammatory conditions. This firm fixed-price delivery order, valued at $11,878.23, represents a non-competitive set-aside award and is scheduled for completion by September 16, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,207.72 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat autoimmune conditions. The contract is a firm fixed-price delivery order with a ceiling value of $1,193.97 and an ultimate completion date of November 25, 2025. This award is non-set-aside and represents a competitive procurement action. The place of performance is AmerisourceBergen's corporate office location...